IRAG
XERS icon

Investment Research & Advisory Group’s Xeris Biopharma Holdings XERS Stock Holding History

Investment Research & Advisory Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-803
Closed -$1K – 181
2022
Q2 		$1K Hold
803
– – ﹤0.01% 177
2022
Q1 		$2K Hold
803
– – ﹤0.01% 185
2021
Q4 		$2K Hold
803
– – ﹤0.01% 189
2021
Q3 		$2K Hold
803
– – ﹤0.01% 143
2021
Q2 		$3K Hold
803
– – ﹤0.01% 172
2021
Q1 		$4K Hold
803
– – ﹤0.01% 132
2020
Q4 		$4K Buy
+803
New +$4.02K ﹤0.01% 136

Other funds holding XERS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Investment Research & Advisory Group's XERS Position: Q3 2022 in Review

Investment Research & Advisory Group sold out of Xeris Biopharma Holdings (XERS) in Q3 2022, closing a stake of 803 shares — an estimated $1K sold.

Investment Research & Advisory Group first reported a position in XERS in Q4 2020 and held it in 7 quarters. The position peaked at $4K in Q1 2021. 101 funds tracked by Wall St. Rank hold XERS as of Q3 2022.

  • Investment Research & Advisory Group reported no remaining Xeris Biopharma Holdings position as of Q3 2022 after selling out during the quarter.
  • Investment Research & Advisory Group sold 803 Xeris Biopharma Holdings shares in Q3 2022, an estimated $1K.
  • Investment Research & Advisory Group first reported a position in Xeris Biopharma Holdings in Q4 2020 and held it in 7 quarters.
  • Investment Research & Advisory Group's Xeris Biopharma Holdings position peaked at $4K in Q1 2021.
  • 101 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2022.

Based on Investment Research & Advisory Group's 13F filing for Q3 2022, filed 18 Oct 2022.